Whether the 2017 ACC/AHA* blood pressure (BP) guidelines should be adopted in Asian countries was the topic of a much-anticipated discussion here at the Asian Pacific Society of Cardiology (APSC) Congress 2018 in Taiwan last week.
Implementation of an electronic national early warning score information system may cut the rate of in-hospital cardiac arrest, as well as improve the rate of survival to discharge, as shown in a study presented at the Asian Pacific Society of Cardiology (APSC) Congress 2018.
Even in the absence of peripheral arterial disease, a lower ankle-brachial index is significantly associated with larger declines in cognitive function, according to a poster presented at the 2018 Congress of the Asian Pacific Society of Cardiology (APSC 2018) in Taipei, Taiwan.
Proprotein convertase subtilisin/kexin 9 (PCSK9) inhibitor is superior to ezetimibe in reducing low-density lipoprotein cholesterol (LDL-C), with or without statin therapy, according to a study presented at the Asian Pacific Society of Cardiology Congress 2018 (APSC 2018) in Taipei, Taiwan. Additionally, PCSK9 inhibitor shows comparable safety profile.
Hepatitis C virus (HCV) infection negatively affects the 12-year mortality in patients following acute myocardial infarction (AMI), as reported in a study from Taiwan. This association is particularly pronounced among males and individuals with hypertension, with cirrhosis further increasing the long-term mortality rates.
The reduction of intraventricular flow energy loss (EL) through biventricular (BiV) pacing appears to be linked to a decrease in the plasma levels of brain natriuretic peptide (BNP), reports a poster presented at the recently concluded 2018 Congress of the Asian Pacific Society of Cardiology (APSC 2018) in Taipei, Taiwan.
Compared to Western populations, the prevalence rates of Brugada syndrome and of sudden unexplained nocturnal death syndrome (SUNDS) are higher in Asia, particularly in the Philippines, reports Dr Giselle Gervacio in the recently concluded 2018 Congress of the Asian Pacific Society of Cardiology (APSC 2018) in Taipei, Taiwan.
A recent genome-wide association study (GWAS) performed by investigators from the Chinese University of Hong Kong (CUHK) has found potential new indications for existing drugs for the treatment of various psychiatric disorders.
The lower 0.25 mg/kg dose of the thrombolytic tenecteplase may be sufficient for reperfusion of blocked vessels prior to thrombectomy in patients with ischaemic stroke due to large-vessel occlusion compared with the 0.4 mg/kg dose, according to the EXTEND-IA TNK* Part 2 study presented at the ISC 2020 Meeting.
The eicosapeptide nerinetide did not improve outcomes in patients with large vessel occlusion-related acute ischaemic stroke who underwent endovascular thrombectomy (EVT). However, patients not treated with alteplase appeared to derive some benefit, results from the multinational ESCAPE-NA1* trial showed.